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When I went to school, they asked me what I wanted to be when I grew up. I wrote 
down ‘happy’. They told me I didn’t understand the assignment, so I told them they 
didn’t understand life. 
-John Lennon 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To my family
  
ABSTRACT 
Obesity is a large health problem and is associated with increased risk of diabetes 
type II, cardiovascular disease as well as implicated in a wide range of gastrointestinal 
disorders such as Crohn’s disease and subclinical bowel inflammation. Obesity is also 
associated with enhanced prevalence of chronic periodontitis in adults. 
The overall aim of this thesis was to investigate if and how the low grade chronic 
inflammation accompanying obesity affects oral health in adolescents. More 
specifically: Study I was designed to investigate whether obesity in adolescence is 
associated with periodontal risk indicators or disease. Study II tests the hypothesis 
whether subgingival microbiological colonization is linked with obesity in 
adolescents. Study III was designed to investigate whether periodontal disease in 
terms of pathological periodontal pockets is associated with raised blood pressure and 
other risk markers for cardiovascular disease (CVD) in obese adolescents. Study IV 
investigates the level of inflammatory markers in saliva and their association to 
salivary flow rate in obese adolescents. 
Obese adolescents (Studies I-IV) and normal weight subjects (Studies I, II and IV) 
within the age range 11-18 years were examined with respect to visible plaque index 
(VPI%), gingival inflammation (bleeding on probing (BOP%)), occurrence of 
pathological pockets exceeding or equal to 4mm (PD≥ 4mm).  
The subjects answered a questionnaire concerning medical conditions, oral 
hygiene habits, smoking habits and sociodemographic background. Body mass index 
(BMI) was calculated and adjusted for age and gender (BMI-sds)  
Samples of gingival crevicular fluid (GCF), subgingival plaque, blood serum and 
stimulated whole saliva were collected and analyzed. Systolic and diastolic blood 
pressures were measured and registered. The flow rate of stimulated whole saliva 
(ml/min) was determined.  
Obese subjects exhibited more BOP> 25% (P< 0.001) and more PD≥ 4mm (P<0.001) 
than the normal weight subjects.  
Higher levels of Interleukin (IL)-1β (P< 0.001) and IL-8 (P= 0.002) were measured 
in GCF from obese subjects compared with the controls. In a multivariate logistic 
regression analysis, BMI-sds (P= 0.03; Odds Ratio (OR) = 1.87) was significantly 
associated with the occurrence of PD≥ 4mm after adjusting for BOP> 25% and 
subgingival calculus. 
The sum of bacterial cells in subgingival biofilm was significantly associated with 
obesity (P< 0.001). The link between sum of bacterial cells and obesity was not 
confounded by any of the studied variables (chronic disease, education, VPI%, BOP%, 
flow rate of whole saliva, or meal frequency). Totally 23 bacterial species were present 
in approximately three-fold higher amounts, on average, in obese subjects compared 
with normal weight controls. Of the Proteobacteria phylum, Campylobacter rectus and 
Neisseria mucosa were present in six-fold higher amounts among obese subjects. 
Obese adolescents with PD≥ 4mm had higher diastolic blood pressure (P= 0.008), 
higher levels of IL-6 (P< 0.001), Leptin (P= 0.018), Macrophage Chemoattractant 
Protein-1 (MCP-1) (P= 0.049) and thyroid stimulating hormone (TSH) (P= 0.004) in 
blood serum compared with subjects without PD≥ 4mm. The bivariate linear 
regression analysis demonstrated that PD≥ 4mm (P= 0.008) and systolic blood 
pressure (P< 0.001) were significantly associated with the dependent variable 
“diastolic blood pressure”. The association between PD≥ 4mm and diastolic blood 
pressure remained significant (P= 0.006) even after adjusting for the potential 
confounders BMI-sds, age, gender, mother’s country of birth, BOP> 25%, IL-6, IL-8, 
Leptin, MCP-1, TSH and total cholesterol in the multiple regression analysis.  
The obese subjects exhibited lower mean value of flow rate of stimulated whole 
saliva, 1.3 vs. 2.0 ml/min (P< 0.001), compared to their normal weight counterparts. 
Obese adolescents had higher levels of salivary Insulin (p< 0.001), Leptin (p= 0.005), 
C-reactive protein (CRP) (p= 0.002) and Interferon (INF)-γ (p= 0.011). Low stimulated 
whole saliva flow rate (< 1.5ml/min) was significantly associated with BMI-sds (p< 
0.001), as well as the biomarkers IL-1β (p= 0.026) and IL-8 (p= 0.013) and the 
associations were not confounded by age, gender, chronic disease, drugs affecting 
salivary flow, PD≥ 4mm and protein content in saliva. 
In conclusion, obesity in adolescents is associated with increased periodontal 
inflammation, increased subgingival microbiological colonization and low flow rate 
of whole saliva. In addition, the presence of pathological periodontal pockets in obese 
adolescents is associated with raised diastolic blood pressure. The results call for 
collaboration between pediatric dentists and medical physicians in preventing obesity 
development and its associated disorders. 
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verweight and obesity are defined as abnormal or excessive fat accumulation 
that presents a risk to health. A crude population measure of obesity is the 
body mass index (BMI), a person’s weight (in kilograms) divided by the 
square of his or her height (in meters). A person with a BMI of 30 or more is generally 
considered obese. A person with a BMI equal to or more than 25 is considered 
overweight. 
Overweight and obesity are major risk factors for a number of chronic diseases, 
including diabetes, cardiovascular diseases and cancer. Once considered a problem 
only in high income countries, overweight and obesity are now dramatically on the 
rise in low- and middle-income countries, particularly in urban settings 1. 
 
 
OBESITY AND OVERWEIGHT IN THE WORLD 
Obesity is the sixth most important risk factor in terms of the number of deaths in 
the world. In 1997, the WHO officially declared obesity to be a chronic condition 
which requires treatment, fosters the development of other diseases, and is connected 
with increased mortality 1.  
Worldwide, the proportion of adults with BMI of 25 kg/m2 or greater increased 
between 1980 and 2013 from 29% to 37% in men, and from 30% to 38% in women. 
Prevalence has increased substantially in children and adolescents in developed 
countries; 23% of boys and 23% of girls under 16 years of age were overweight or 
obese in 2013. The prevalence of overweight and obesity has also increased in children 
and adolescents in developing countries, from 8% to 13% in 2013 for boys and from 
8% to 13% in girls. In adults, estimated prevalence of obesity exceeded 50% in men in 
Tonga and in women in Kuwait, Kiribati, Federated States of Micronesia, Libya, Qatar, 
Tonga and Samoa. Since 2006, the increase in adult obesity in developed countries has 
started to level out 2. 
ETIOLOGY OF OBESITY 
The rising epidemic of overweight and obesity reflects the profound changes in 
society and in behavioral patterns of communities in recent decades.  Incomes rise, 
populations become more urban and their diet changes to include more ready-
prepared meals, fast foods, increased snacking and high sugar-containing drinks 3, 4 
such a diet is higher in fats, saturated fats and sugars. At the same time, the population 
worldwide is shifting towards less physically demanding work, mostly due to the 
increase in the number of computers and machines at work. Also on the increase is 
the use of automated transport (cars, buses, trains, escalators and elevators) 5, 
technology in the home (television, computers and computer games, etc.) and more 
passive leisure pursuits 1, 6-8. Less physical activity is in general the modern style of 
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life. In more academic terms these changes could be described as: economic growth, 
modernization, urbanization and globalization of the food market 1. 
GENETIC INFLUENCES ON OBESITY 
Genes are important in determining a person's susceptibility to weight gain, but 
the genetic factors predisposing to obesity are poorly understood. Early studies 
indicate that obesity runs along family lines 9-14, this seems logical if you presume that 
a family would share the same diet and physical activity interests. However, a Danish 
study showed that adopted children had a BMI closer related to their biological 
parents that to the adopted parents 15.  
One gene in particular has been associated with obesity, the FTO-gene.  This gene 
is situated on chromosome 16 and was first mentioned in connection to obesity in 2007 
16. There is especially a positive association between FTO gene polymorphism and 
overweight/obesity risk among children and adolescents 17. In addition, it appears 
that FTO-gene variants are associated with a preference for energy-dense foods, 
greater food intake, less sensitivity to satiety cues and loss-of-control eating 
episodes18. 
There are also several genetic syndromes connected with obesity. Many have a 
characteristic presentation and several, an overlapping phenotype indicating there 
might be a shared common underlying mechanism or pathway. Most common 
amongst obesity syndromes is Prader-Willi, caused by the loss of imprinted genes on 
15q11-13. There are several other syndromes as well: Bardet-Biedl syndrome, Alstrom 
syndrome, Cohen syndrome, Carpenter syndrome, MOMO syndrome Rubinstein-
Taybi syndrome, cases with deletions of 6q16, 1p36, 2q37 and 9q34, 19. All obesity 
related syndromes are rare and always connected with further symptoms. A German 
specialized clinic for endocrinology and obesity screened all new patients for genetic 
syndromes disorders and less than 1% of 1405 patients were diagnosed 20.  
OBESITY AND MICROBIOLOGY 
The healthy human microbiota is comprised of 1014 microorganisms, at least 10 
times the amount of all human cells in the body. Most indigenous microbes reside in 
the colon 21, 22. Collectively, the human microbiota encodes 150 times more genes than 
the human genome (3-4 million) 23. This enables the microbiota to perform diverse 
metabolic activities not encoded in the human genome24. Approximately 500–1000 
different bacterial species comprise this busy ecosystem. Factors influencing the 
microbiota composition include age, diet, antibiotics and most of the elements of a 
modern lifestyle in addition to certain disease states. From birth, the microbiome and 
host immune system co-develop and are mutually inter-dependent 25. Thus, the 
microbiota shapes the development of the immune system, and in turn the immune 
system shapes the composition of the microbiota. Disruption or sustained changes to 
the gut microbiota may be associated with obesity 26 and insulin resistance 27.  
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COMPOSITION OF GUT MICROBIOTA 
The phylum Firmicutes (including Clostridium, Enterococcus, Lactobacillus and 
Ruminococcus) and Bacteroidetes (including Prevotella and Bacteroides genera) 
constitute over 90% of known phylogenetic categories and dominate the distal gut 
microbiota in humans 28. Obese individuals, however, demonstrate differences in gut 
microbiota at the phylum level, with less overall diversity 29 and greater proportion of 
Firmicutes than Bacteroidetes, compared with normal weigh individuals 29, 30. 
However these findings are not universal, a number of other studies have 
demonstrated variable patterns in phylum level changes measured in the composition 
of the microbiota of obese subjects 31, 32.  
ENERGY HARVEST 
The gut microbiota significantly affects energy yield from diet. Hydrolysis and 
fermentation of otherwise indigestible dietary polysaccharides by the gut microbiota 
enhances host energy harvest. The proximal small intestine and stomach are 
responsible for most nutrient digestion and absorption. Normally, almost all fats, 
∼85% of carbohydrates and 65–95% of proteins are absorbed prior to entering the 
colon33. The remaining indigestible nutrients would be generally excreted without 
absorption if not for colonic microbiota, which enhance energy uptake or harvest from 
ingested food. Bacteroidetes are reported to encode higher levels of carbohydrate 
active enzymes than Firmicutes 34.  
Over nutrition is associated with raised Firmicutes versus Bacteroidetes ratio. 
Interestingly, in lean subjects phylum level changes in the fecal microbiota were 
significantly associated with stool energy loss, positively associated with proportional 
increase in Bacteroidetes, the opposite for Firmicutes 21, 35. 
OBESITY IS CHRONIC INFLAMMATION 
Adipose (fat) tissue is where the body stores the excess energy consumed as lipids. 
It is also a tissue that produces a wide range of inflammatory cytokines, often called 
adipocytokines or adipokines 36-40. More than a hundred adipose tissue secretion 
products have been described including fatty acids, prostaglandins and steroids, as 
well as complex proteins 41.  
Cytokines have been found to be central to the pathogenesis of an ever-increasing 
number of diseases. They are inter-cellular messengers and, as such, represent a key 
mechanism by which cells involved in immune response communicate.  
People who are overweight and obese have larger quantities of adipose tissue 
which leads to an increased production and secretion of adipokines 42. Fain observed 
in 2006 that the total release of Tumor necrosis factor (TNF)-α, IL-6 and IL-8 by adipose 
tissue was markedly elevated in obese patients 39. It has also been reported that 
adipose tissue in an obese person is infiltrated by macrophages to a higher 
concentration than in a normal weight person, which may be a major source of 
secreted adipokines 43. In addition, it has been reported that other inflammatory cell 
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types, such as T-lymphocytes, also infiltrate the obese adipose tissue and contribute 
to adipose tissue inflammation 44. This overproduction of adipokines has effects on 
both local and distant sites, influencing important biological processes including lipid 
homeostasis, immune function, insulin sensitivity, control of blood pressure, appetite 
and energy balance 37, 45. 
Leptin was the first adipocyte hormone discovered. Its most known effect is that it 
increases a person’s appetite. It is also believed to be involved in a variety of biological 
processes, for example to regulate adipose tissue mass. Elevated leptin concentrations 
result in increased energy expenditure, decreased food intake and a negative energy 
balance 46. Most overweight and obese persons show resistance to leptin at the 
receptor level, leading to higher leptin levels than normal weight individuals 47. In 
addition, several studies have suggested that elevated levels of leptin can be found 
during infection and inflammation 48.  
Plasminogen activator inhibitor-1 (PAI-1) is the principal inhibitor of tissue 
plasminogen activator and urokinase, the activators of plasminogen and hence 
fibrinolysis.  
Resistin in rodents has been shown to induce insulin resistance, while in humans 
its implication in the control of insulin sensitivity is still a matter of debate. Current 
evidence suggests that, in humans, resistin is more closely related to inflammatory 
processes than to insulin resistance 49, 50.  
Adiponectin, an insulin-sensitizing effector, is down-regulated during obesity. 
Circulating adiponectin levels are also decreased in subjects with obesity-related 
insulin resistance, type-2 diabetes and coronary heart disease. In addition, adiponectin 
counteracts the pro-inflammatory effects of TNF-α on the arterial wall and probably 
protects against the development of arteriosclerosis.  
TNF-α is believed to have an important role in the pathogenesis of insulin 
resistance and IL-6 induces hepatic CRP synthesis and may promote the onset of 
cardiovascular complications. Both TNF-α and IL-6 can alter insulin sensitivity by 
triggering different key steps in the insulin signaling pathway 42, 51, 52.   
The full effects of these pro-inflammatory factors and how exactly they trigger or 
inhibit different physiological reactions are not yet properly understood but research 
on mainly rodents is starting to indicate how and why these changes in human 
physiology occur 44, 53. 
OBESITY AND HEALTH  
Obesity is currently considered as a chronic disease which must be treated like any 
other medical condition.  It has an epidemic-like nature and is not only one of the main 
causes of morbidity and mortality, in particular in developed countries, but also 
causes huge social and economic burdens 54, 55. Overweight and obesity increases the 
risk of type 2 diabetes, cardiovascular diseases and several forms of cancer. In 
addition, excess bodyweight contributes to disabling disorders such as osteoarthritis, 
 7 
 
infertility, asthma and sleep apnea. Maternal obesity has also been linked to an 
increased risk of congenital anomalies 56.  
MEDICAL CONSEQUENCES OF CHILDHOOD OBESITY 
Childhood obesity can adversely affect nearly every organ system (Figure 1) and 
often causes serious consequences including hypertension, dyslipidemia, insulin 
resistance/diabetes, fatty liver disease and psychosocial complications. In addition, 
atherosclerotic process appears to be accelerated in obese children. BMI in childhood 
and adolescence is associated with increased risk of cardiovascular disease in 
adulthood 57. 
 
 
Figure 1. Medical complications associated with childhood obesity 
Image obtained by dual energy x-ray absorptiometry from a teenage girl with BMI 38 kg/m2. Disorders 
that are of high prevalence and are well established in their association with childhood obesity are 
shown in pink. CNS=central nervous system. PCOS=polycystic ovary syndrome. SCFE=slipped capital 
femoral epiphysis. Figure courtesy of Han et al. Lancet 2010. 
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PSYCHOSOCIAL COMORBIDITIES 
 Anxiety, depression, stress, low self-esteem, bullying, social withdrawal 
and lower quality of life have been reported to be more common in obese 
adolescents 58, 59. 
 Poor school performance, including difficulty with concentration and 
missed school days, are 4 times more likely in an obese adolescent 
population when compared with their normal weight counterparts 58, 59. 
 Overweight/obese adolescents show higher lifetime rates of eating 
disorders, especially bulimia nervosa, than population-based samples 58, 59. 
METABOLIC SYNDROME 
In adults, the metabolic syndrome is defined as a clustering of features including 
insulin resistance/elevated glucose, hypertension, abdominal obesity and 
dyslipidemia that portends risk for type 2 diabetes and CVD 60. The metabolic 
syndrome is also prevalent in other conditions linked to insulin resistance, such as 
polycystic ovarian syndrome and nonalcoholic fatty liver disease 61, 62.  
International Diabetes Federation Task Force on Epidemiology and Prevention; 
National Heart, Lung, and Blood Institute; American Heart Association; World Heart 
Federation; International Atherosclerosis Society; and International Association for 
the Study of Obesity joint statement of diagnosis guidelines for metabolic syndrome60: 
 
Central obesity 
 Waist circumference—ethnicity specific 
Plus any two: 
 Raised triglycerides 
o >150 mg/dL (1·7 mmol/L) 
 Specific treatment for this lipid abnormality 
 Reduced HDL-cholesterol 
o <40 mg/dL (1·03 mmol/L) in men 
o <50 mg/dL (1·29 mmol/L) in women 
 Specific treatment for this lipid abnormality 
 Raised blood pressure 
o Systolic ⩾130 mm Hg 
o Diastolic ⩾85 mm Hg 
 Treatment of previously diagnosed hypertension  
 Fasting plasma glucose 
o  ⩾100 mg/dL (5·6 mmol/L) 
 Previously diagnosed type 2 diabetes 
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In children and adolescents, the metabolic syndrome is defined in a similar cluster 
but there is no single generally accepted definition 63. A systematic review of studies 
performed in the pediatric age range indicates a prevalence of metabolic syndrome in 
population-based studies of 3.3%, 11.9%, and 29.2% of normal-weight, overweight, 
and obese children, respectively 62, 64. Almost half of children with BMI ≥ 97th 
percentile have one or more of the conditions which comprise the metabolic 
syndrome57. 
OBESITY AND ORAL HEALTH 
OBESITY, CRANIOFACIAL AND DENTAL DEVELOPMENT  
Obese adolescents have been shown to develop an increased mandibular length, 
prognatic jaws and a reduced upper anterior face height 65. They also have an 
accelerated dental development and skeletal maturity 66, 67. These are important 
factors to consider in pediatric and orthodontic treatment planning where timing is 
crucial. 
OBESITY AND DENTAL CARIES 
Both dental caries and obesity are diseases with multifactor etiology related to 
dietary habits but also closely correlated with sociodemographic background of the 
individuals. National data from Sweden suggest a positive correlation between dental 
caries and BMI, as well as, demonstrated that obesogenic behavior such as snacking 
in between meals predicted caries development in adolescence 68. In addition, recent 
studies link obesity, dental caries and high sugar intake 69-71.  
The majority of studies regarding association between obesity and dental caries 
are based on clinical data expressing caries experience that reflect not only the actual 
caries situation but also previous accumulation of caries and filled surfaces.  Several 
clinical studies demonstrates a relationship between obesity and dental caries 68, 69, 72-
75, but contradictory results are also present 76, 77. Longitudinal studies present 
evidence of the association between overweight/obesity and dental caries as 
conflicting and inconclusive 78. Major confounders for association between dental 
caries and obesity are the population’s access to oral health services, use of fluorinated 
substances, socioeconomic and dietary conditions. Generally European studies 
showed an association between obesity and dental caries whereas Latin-American 
studies did not. Both continents have similar access to fluoridated 
products/fluoridated water supply but vary in socioeconomic and dietary conditions 
79. 
In addition, obese adolescents exhibit a lower flow rate of stimulated whole saliva 
compared to normal-weight controls and this may explain part of the possible link 
between obesity and dental caries 80. 
  
 10 
 
OBESITY AND SALIVA 
Saliva secretion is essential for adequate functions such as chewing and 
swallowing and hypo-salivation may trigger many oral problems 81. Normal 
salivation and salivary components initiate digestion, enhance healing of mucosa and 
maintain oral microflora in balance 82. Several studies demonstrate an association 
between obesity and reduced flow rate of saliva in adults and adolescents 80, 81, but not 
in younger children 83, 84.  
Adipose tissue is well known to secrete and affect the regulation of a number of 
pro- and anti-inflammatory cytokines, so-called adipokines, including TNF-α, Il-1β, 
IL-6, IL-8, leptin, plasminogen activator inhibitor-1, resistin and adiponectin 36, 85. In 
turn, this dysregulation of adipokines may increase both the risk and the development 
of chronic and autoimmune disease 86. 
Both human and animal studies indicate that levels of inflammatory cytokines in 
saliva are associated with decreased salivary flow 87-89. In addition, during the last few 
years, several studies concerning inflammatory markers in saliva from obese subjects 
have been published. In obese populations of adults and children decreased levels of 
adiponectin 83, 90 and in children increased levels of CRP, salivary insulin and leptin 
have been reported 83. Interestingly, obese subjects have also been reported to exhibit 
a significant enlargement of parotid glands probably by an enhanced storage of 
adipocytes in the parotid parenchyma whereas the submandibular glands seem to 
remain unaffected 91, 92.  
There are, as well, several reports indicating that saliva from obese patients 
suppresses some taste aromas and that salivary composition, sensitivity to dietary fat 
intake and oral postprandial lipid metabolism is affected in obese subjects 93, 94. All 
these indicate that salivary composition and function may be altered in obese patients 
83, 93-96.  
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OBESITY AND PERIODONTAL DISEASE 
Periodontal disease is a bacterial infection involving the dental biofilm. Some of 
the periodontal pathogens in subgingival microbiome have been identified to have 
virulence potential and are associated with the etiology and the pathogenesis of 
periodontal disease. Biofilms that cause gingivitis and periodontitis are site-specific, 
complex poly-microbial communities that are resistant to host-defense mechanisms 
and difficult to treat with antimicrobial agent, especially with long term results. 
However, the rate of progression, age at onset and severity of periodontal disease in 
an individual are determined by systemic risk factors in the specific individual (figure 
2) 97. 
 
Figure 2. Potential risk factors for periodontal disease. The error bars represent the 95% 
confidence intervals. If 95% confidence intervals do not cross the odds ratio 1.0 they are statistically 
significant at P ≤ 0.05. Odds ratios >1 can be considered to increase risk for periodontal clinical 
attachment loss, and may be risk factors; odds ratios <1 are associated with less attachment loss, and 
may be protective factors. Data from Genco et al 2013 and Gossi et al 1995 97, 98. 
 
The first report on the relationship between obesity and periodontal disease was 
published in 1977, when a research group observed histopathologic changes in the 
periodontium of hereditary obese Zucker rats 99 but not until 1998 was an association 
between obesity and periodontal disease shown in humans 100. 
Several cross-sectional studies have since reported that obesity is associated with 
enhanced prevalence of chronic periodontitis in adults over 17 years of age 100-102. 
More recently, large longitudinal studies, from 5 to 40 years duration, demonstrate 
that both overall obesity and central adiposity are associated with an increased risk 
and faster progression of periodontal disease 97.  
Before our first study there were no published studies reporting an association 
between obesity and periodontal disease in children and adolescents under 17 years 
of age. At present, the available literature on a possible association between obesity 
and periodontal disease is inconclusive. In addition, published studies use different 
-1 0 1 2 3 4 5 6 7 8 9 10 11
Education
Allergy
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measurements and cut off values for gingival inflammation and pathological 
periodontal pockets, making results difficult to compare 103-105. 
The mechanism(s) whereby obesity may affect periodontal health is so far unclear. 
In an animal model, however, obesity interferes with the ability of the immune system 
to appropriately respond to the periodontal pathogen Porphyromonas gingivalis 
infection in terms of TNF-α, IL-6 and serum amyloid response, suggesting that this 
immune dysregulation participates in the increased alveolar bone loss after bacterial 
infection 106.  
In adolescents 18 years of age with severe obesity, it has previously been reported 
that the level of TNF-α in GCF is positively correlated with BMI, indicating that the 
level of TNF-α in GCF was affected by the obese condition 107.  
Circulating adipokines might also influence the immune response at the mucosal 
level both in the oral cavity and in the gut, thereby affecting the microbial 
colonization. Whether there is a relationship between obesity and the oral microbiota 
is so far unclear. In an animal model, however, obesity has been reported to interfere 
with the ability of the immune system to appropriately respond to infection by the 
periodontal pathogen Porphyromonas gingivalis 106. Furthermore, enhanced 
colonization of Tannerella forsythia in subgingival biofilm has been reported in obese 
subjects 108.  
OBESITY, METABOLIC DISORDERS, CVD AND PERIODONTAL DISEASE 
The current epidemiological data indicate that there is an association between 
periodontal disease and hypertension in adults 109, 110. Systemic inflammatory 
response associated with periodontal disease has been proposed to have adverse 
effects on blood pressure 109. Periodontitis may also be capable of inducing vascular 
inflammation, which leads to endothelial dysfunction, an initial step for CVD 109.  In 
fact, this association may be multidirectional. For example, it has been well-
established that inflammation is an essential component in the development of 
atherosclerosis, and observational studies showed that periodontitis is associated with 
a higher risk of coronary heart disease 111-113. There are several studies presenting 
evidence of the oral infection theory of atherogenesis 114. Periodontal pathogens are 
able to cause transient bacteremia, invading the arterial wall and possibly lead to 
vascular inflammation and atherosclerosis 109. Inflammatory diseases like 
periodontitis induce the production of pro-inflammatory cytokines such as TNF-α, IL-
1 and IL-6 115. It has been suggested that the secretion of TNF-α by adipose tissue 
triggered by lipopolysaccharide (LPS) from periodontal gram-negative bacteria 
promotes hepatic dyslipidemia and decreases insulin sensitivity 116, 117. There are 
studies reporting an association between periodontitis, impaired fasting glucose and 
diabetes type 2 118. Type 2 diabetes and decreased insulin sensitivity are associated 
with the production of advanced glycation end-products, which trigger inflammatory 
cytokine production, thus predisposing for inflammatory diseases such as 
periodontitis 117.  
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Interestingly, periodontal therapy has been demonstrated, in clinical intervention 
studies, to decrease levels of biomarkers CRP and IL-6 in serum as well as improving 
endothelial function 109, 119. Periodontal treatment also seems to reduce levels of 
cholesterol and triglycerides both in adults 120, 121 and children 122. In addition, 
periodontal treatment may reduce circulating TNF-α and serum levels of glycosylated 
hemoglobin, and has beneficial effects on the control of type 2 diabetes 117. There is, as 
well, emerging evidence that successful periodontal treatment might help reduce 
blood pressure in patients with hypertension 123.  
Periodontitis, once it exists, may promote systemic inflammation and thereby 
increase the risk and progression of obesity co-morbities 111, 115.  
GINGIVAL CREVICULAR FLUID 
GCF is mainly an inflammatory exudate that is collected in the gingival crevices 
surrounding the teeth 124-126.  GCF components have a variety of sources and contain 
substances originating from the host as well as from micro-organisms in subgingival 
and supragingival plaque. Substances from the host include molecules from the blood 
as well as contributions from periodontal cells and tissues. When micro-organisms in 
the dental biofilm initiate an inflammatory response, various inflammatory mediators 
are produced. These mediators: cytokines, prostaglandins, and enzymes like matrix 
metalloproteinase (MMPs) can be detected in GCF 127-134. 
The collection and analysis of GCF is a non-invasive method for evaluating the 
host response to periodontal disease. The volume of GCF present at a site may be 
directly related to tissue inflammation as well as permeability and ulceration of the 
crevicular epithelium. As inflammation deteriorates gingival health, the volume of 
GCF increases 135.  
 
One of the methods of collecting GCF is with 
paper strips (Figure 3). The advantages of using 
a paper strip are that the method is quick, easy, 
and individual sites can be sampled separately. 
Furthermore, using paper strips correctly is, 
most likely, the least traumatic method available 
to collect GCF from the gingival crevice 130.  
 
 
Figure 3. GCF collecting with paper strip. 
(Courtesy of Prof. Modéer and Dr Tsilingaridis) 
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AIM OF THE THESIS 
The overall aim of this thesis was to investigate if and how the low grade chronic 
inflammation accompanying obesity affects oral health in adolescents.  
SPECIFIC AIMS  
STUDY I  
In a cross-sectional study design we test the hypothesis whether obesity in 
adolescence is associated with periodontal risk indicators. 
STUDY II 
In this study we investigate whether microbiota in subgingival plaque is linked 
with obesity in adolescents. 
STUDY III  
This study in obese adolescents was designed to investigate whether periodontal 
disease in terms of pathological periodontal pockets is associated with raised blood 
pressure and other risk markers for CVD. 
STUDY IV 
We designed this cross-sectional study to investigate the levels of inflammatory 
markers in saliva and their association to salivary flow rate in obese adolescents.  
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MATERIALS AND METHODS 
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his section gives a brief overview of the methods used to obtain the results 
presented in this thesis. The study design was cross-sectional and the Ethics 
Committee at Karolinska University Hospital, Karolinska Institutet, 
Huddinge, Sweden, approved the study protocol, methods and selection of subjects. 
Subjects and/or their parents received verbal as well as written information, and all 
subjects and/or their parents gave their informed consent for participation in the 
studies. 
 
 
STUDY POPULATION 
 
 
Obese: 
Referred from 
National Childhood Obesity Center,  
Karolinska University Hospital 
  
Normal weight: 
Recruited from 
Division of Pediatric Dentistry, 
Department of Dental Medicine, 
Karolinska Institutet 
 
 
 
 
Study I 
 
 
Study II 
 
Study III 
 
Study IV 
    
obese 
52 
normal 
weight 
52 
 
obese 
29 
 
normal 
weight 
58 
obese 
75 
 
obese 
55 
 
normal 
weight 
67 
 
years  
14.5 
 
Years 
14.5 
 
years 
14.5 
 
years 
14.5 
 
years 
14.5 
 
years 
14.3 
 
 
years 
14.1 
 
 
Boy/ Girl 
29/23 
Boy/ Girl 
29/23 
 
Boy/ Girl 
18/11 
Boy/ Girl 
36/22 
 
Boy/ Girl 
42/33 
Boy/ Girl 
28/23 
Boy/ Girl 
37/30 
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Inclusion criteria: 
Obese subjects: ISO-BMI> 30kg/m2 
Normal weight subjects: ISO-BMI< 25kg/m2  136 
 
Exclusion criteria:  
Studies I-IV 
Antibiotic treatment during the last 3 months. 
Ongoing orthodontic treatment. 
Current daily smoking  
Study III 
Under 12 years of age. 
Incomplete sample sets.  
QUESTIONNAIRE 
All the subjects answered a questionnaire that covered topics of their medical 
condition, medication, dietary habits and oral hygiene habits as well as their parents’ 
educational level and country of birth. In case subjects did not understand the 
Swedish language, an interpreter assisted. Parents’ country of birth was categorized 
into “born in Sweden” or “born abroad”.  
Participants under 18 years were assisted by a parent when answering the 
questionnaire. 
CLINICAL EXAMINATION 
DENTAL PLAQUE AND GINGIVAL INFLAMMATION (STUDIES I-IV) 
The presence of dental plaque on tooth surfaces were recorded when clearly visible 
and expressed using VPI%. Gingival inflammation was based on BOP% of the 
gingival sulcus of all teeth (wisdom teeth excluded) at six sites of each tooth 137. The 
proportion of surfaces (%) with visible dental plaque and gingival inflammation, 
respectively, was calculated for each subject. 
PATHOLOGICAL PERIODONTAL POCKETS (STUDIES I- IV) 
 Pocket depth (mm) was recorded by using a graded periodontal probe (LM-
instruments OY, Finland) and measured to the nearest mm. The occurrence of 
pathological periodontal pocket was classified when the subject exhibited one or more 
sites with a pocket depth of ≥4mm. 
CALCULUS (STUDIES I AND II) 
Supragingival calculus was recorded on all teeth as present or absent when clearly 
visible. Subgingival calculus was recorded as present or absent on proximal surfaces 
of first molar and premolars on the radiographs taken as well as clinically after 
probing the gingival sulcus.   
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INCIPIENT ALVEOLAR BONE LOSS (STUDIES I AND II) 
In order to determine marginal alveolar bone loss, 2 bitewing radiographs were 
taken using standardized technique. The distance between cemento-enamel junction 
(CEJ) and alveolar bone crest (AC) on the radiographs was measured on the mesial 
and distal surfaces of premolars and first molar by using a Peak scale loupe (Carton 
Optic Tokyo Japan; 7-fold magnification). Incipient marginal alveolar bone loss was 
classified as positive when the distance from CEJ to AC on the radiographs was ≥2 
mm 138.  
CREVICULAR FLUID SAMPLES (STUDY I) 
GCF was collected at two sites, 16 and 41 from each subject using a paper strip 
(Periopaper, Proflow, Inc Amityville, N.Y., USA). The strip was inserted into the 
gingival crevice and left for 30 seconds. The strip was then analyzed using Periotron 
8000 sensor and the volume was calculated by interpolation from a standard curve 
and expressed as µL GCF. The periopaper was placed in 120 µL assay buffer 
containing 0.9% Na Cl, 0.01 M EDTA, 0.3% bovine-globulin, 0.005 % Triton-X-100, 
0.05% sodium azide, 0.0255 M NaH2 PO4, 0.0245 M Na2HPO4, PH 6.8 and kept frozen 
at -70oC 23. 
The GCF samples were analyzed with respect to the levels of adiponectin, IL-1β, 
IL-6, IL-8 and PAI-1 by using commercially available kits (Linco Research, Inc., 
Missouri, USA) in accordance with the manufacturer’s instruction. TNF-α levels were 
measured using Bio-Plex cytokine assay (Bio-Rad laboratories, California, USA). 
MICROBIOLOGICAL SAMPLING (STUDY II) 
Before sampling, supra gingival plaque was eliminated and the gingival margins 
were wiped dry with a sterile cotton pellet. Samples of subgingival plaque were taken 
from one molar in the lower jaw and one incisor site in the upper jaw with a sterile 
paper point. The paper point (Precise Dental Internacional S.A de C.V, Mexico. Size 40) 
was inserted into the gingival crevice for 5 seconds. The paper points were stored in 
Eppendorf tubes at -70°C until analyzed with respect to microbiology. We analyzed 
the samples using the checkerboard DNA-DNA hybridization technique. A total of 37 
bacterial species and 3 subspecies were included in the checkerboard panel.  
BLOOD PRESSURE (STUDY III) 
Systolic and diastolic blood pressure were measured in the sitting position with a 
mercury sphygmomanometer with a standard pressure cuff of the correct size on the 
left arm. Blood pressures were measured in duplicates. A third measurement was 
taken if the two readings differed more than 5 mm Hg and the mean of the two closest 
readings was used. The same experienced nurse practitioner performed all 
measurements.  
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BLOOD SAMPLES (STUDY III) 
Blood samples were taken after an overnight fast starting at midnight. Fasting was 
confirmed by the child and parent before collecting blood. Blood samples for HDL 
were analyzed immediately. Remaining samples were kept frozen in -80°C until 
analyzed. High density lipoprotein-cholesterol (HDL-C), TSH and CRP-sensitivity 
analyses were performed at a certified laboratory (Department of Clinical Chemistry, 
Karolinska University Hospital). IL-1β, IL-6, IL-8, MCP-1 and Leptin were analyzed 
using commercially available Luminex kits (Linco Research, Inc., Missouri, USA). 
TNF-α levels were measured using Bio-Plex cytokine assay (Bio-Rad laboratories, 
California, USA). 
SALIVA (STUDY IV)  
Before the saliva collection, the subjects rinsed the mouth with water. Stimulated 
whole saliva was collected by chewing 1g of paraffin wax for 5 minutes, and during 
this time the subjects spit the saliva into a test tube. The saliva was then measured and 
the saliva flow rate was expressed as ml/min. For further analysis, 1 ml of saliva was 
measured and within 10 minutes frozen and stored at -80°C until further analysis. 
Total amount of protein in the salivary samples was quantified using a NanoVue Plus 
spectrophotometer (GE Healthcare, Uppsala, Sweden). The saliva samples were 
analyzed with respect to the levels of adiponectin, Insulin, Resistin, IL-1β, IL-6, IL-8, 
TNF-α, IL-4, IL-17 and INF-γ using Luminex technology on a Bioplex Suspension 
Array System (Bio-Rad Laboratories, Hercules, CA, USA) with commercially 
available Milliplex® Map kits (EMD Millipore Corporation, Billerica, MA, USA) in 
accordance with the manufacturer’s instruction. Leptin and CRP were analyzed using 
commercially available ELISA-kits (R&D Systems, Minneapolis, MN, USA).  
STATISTICS 
STUDIES I-IV 
Data analysis was carried out using the statistical software package SPSS, version 
16.0-22.0 (SPSS, Chicago, IL, USA). For analyzing the data, frequency tables, cross 
tables, ANOVA, Chi-square and logistic regression were used. In the logistic 
regression analysis the Wald test was also performed. The OR and confidence interval 
(95% CI) were calculated and the level of significance was accepted at P-values less 
than 0.05. 
STUDY I 
Bivariate analyses association was carried out between the dependent variable 
“pathological periodontal pocket (PD≥ 4mm)” and the independent variables by 
applying logistic regression binary model. In the multiple logistic regression analysis 
with pathological periodontal pocket as dependent variable, the independent variable 
BMI-sds was adjusted for potential confounders.  
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STUDY II 
Bivariate analyses of associations were carried out between the dependent variable 
obesity and the potential independent variables. Pearson’s correlation test was used 
to determine intra correlations between potential confounders. In the multivariate 
logistic regression with obesity as dependent variable the variable “sum of bacterial 
cells” was adjusted for the strongest variable of the intracorrelating potential 
confounders. In case of the microbiological variables, the Bonferroni test estimated, a 
P-value of < 0.01 was required to declare significance to avoid chance of mass 
significance. In addition, the sensitivity and specificity for bacterial sum as a 
discriminator of obesity were also determined.  
STUDY III 
Bivariate analyses were carried out between the dependent variable diastolic blood 
pressure or systolic blood pressure and the independent variables by applying a linear 
regression model. In the multiple linear regression analysis with diastolic blood 
pressure as dependent variable, the independent variable PD ≤ 4mm was adjusted for 
potential confounders (BMI-sds, age, gender, mother’s country of birth, BOP >25%, 
IL-6, IL-8, Leptin, MCP-1, TSH and total cholesterol). 
Confidence Interval 95% was calculated. Level of significance was accepted at P-
values less than 0.05. In case of biochemical variables, the Bonferroni test adjusted for 
intracorrelations between the biomedical variables and a P-value of <0.01 was 
required to declare significance to avoid chance of mass significance.  
STUDY IV 
Bivariate and multivariate logistic regression models were used to check for 
potential confounders. Bivariate analyses of associations were carried out between the 
dependent variable “flow rate of stimulated whole saliva less than the median value 
(<1.5 ml/min)” and independent variables by logistic regression binary model. In the 
multivariate logistic regression, with “flow rate of stimulated whole saliva (< 1.5 
ml/min)” as dependent variable, the independent variables BMI-sds, IL-1β and IL-8 
were adjusted for potential confounders. The OR and 95% CI was calculated and the 
level of significance was accepted at P-values less than 0.05.  
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RESULTS AND DISCUSSION 
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his chapter gives a brief overview of the results in the studies included in the 
thesis and discusses them in relation to current literature. This thesis 
investigates oral health in adolescents with obesity with focus on periodontal 
inflammation, subgingival microflora and salivary flow rate. Study I focuses on 
periodontal risk indicators and their association to obesity. Study II was designed to 
test whether microbiota in the oral biofilm is linked with obesity. Study III takes the 
subject further and investigates if periodontal diseases in terms of pathological 
periodontal pockets may be associated with raised blood pressure and other risk 
markers for CVD. Study IV was designed and conducted to investigate the 
association between obesity and reduced stimulated whole salivary flow. The first 
three studies have been published and the fourth study is in manuscript form. All four 
studies can be found in their entirety in the appendix.  
 
 
SOCIODEMOGRAPHIC AND MEDICAL CONDITION OF THE 
SUBJECTS 
There was no difference between the obese and normal weight subjects in regards 
to parents’ country of birth or level of education (Studies I, II and IV). There are 
several other socio-economic variables that we did not take into consideration, which 
could differ between the groups and affect the results.  
Obese subjects were significantly more likely to have a chronic disease diagnosis 
and more likely to take one or more prescribed medication (Studies I, II and IV). This 
might also have an impact on the results, as chronic illnesses such as diabetes type 2, 
CVD, chronic kidney diseases and celiac disease are associated with negatively 
impacted oral health 139, 140. As chronic disease and metabolic factors are also highly 
associated with obesity, it is hard to evaluate the effect of each components on the 
inter-relationship between oral health, obesity and chronic disease 141. 
ORAL HYGIENE AND GINGIVAL INFLAMMATION 
The obese subjects demonstrated significantly lower frequency of tooth brushing 
(P<0.05) (Studies I, II and IV), use of dental floss (P<0.05) (Study I) and significant 
higher frequency of VPI >25% (P<0.05) (Studies I, II and IV). Adolescents with 
obesity exhibited higher prevalence of BOP >25% (P<0.05) (Studies I, II and IV).  Our 
results concerning both oral hygiene habits and gingival inflammation have been 
concurred by several later studies investigating oral health in obese children 
worldwide 105, 142-145. 
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PATHOLOGICAL PERIODONTAL POCKETS (STUDY I) 
Obese subjects demonstrated higher frequency of PD≥  4mm (P< 0.001) than their 
normal weight counterparts. We further tested the association between BMI-sds and 
PD≥ 4mm using a multiple logistic regression model. The variable BMI-sds was 
significantly (P=0.030) associated with the occurrence of PD≥ 4mm even after 
adjusting for the variables BOP (>25%), and subgingival calculus. Altogether the 
multivariate analysis demonstrates that obese adolescents exhibit an enhanced 
relative risk for exhibiting pathological periodontal pockets that is not caused by 
worse oral hygiene alone.  
There are very few published studies on pathological periodontal pockets and 
obesity in a population under 18 years old. Reeves et al. found an association between 
periodontal pockets >3mm and obesity in a population 17 to 21 years of age but not 
in 13-16 year olds 102. Fadel et al. did not demonstrate an association between obesity 
and periodontal pockets >5mm 144. As to date, there are no longitudinal studies on 
obesity and periodontal disease involving children and adolescents. 
 
ADIPOKINES IN GCF (STUDY I) 
IL-1β and IL-8 in GCF were significantly higher in the obese subjects compared 
with normal weight controls (Figure 3).   
          
Figure 3. Levels of Il-8 and Il-1β in GCF. 
 
Levels of Adiponectin, PAI-1 and TNF-α in GCF did not differ significantly 
between the groups. 
A possible explanation of the enhanced relative risk of periodontal disease in 
obesity seems to lie with adipose derived adipokines present in periodontal disease 
146. The enhanced level of cytokines in GCF reported in obese subjects may to some 
extent be produced by adipose tissue and we hypothesize that obesity either directly 
or indirectly contributes to an enhanced pro-inflammatory milieu in the periodontal 
IL-8 ng/ml 
IL-1β ng/ml 
        Obese                   Normal         Obese                   Normal 
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tissue that triggers the inflammatory response to periodontal pathogens residing in 
the biofilm. Adipokines bind receptors on target cells and initiate intercellular 
signaling cascades resulting in phenotypic changes to the cell through altered gene 
expression and regulation. These adipocytokines activate monocytes which increas 
the production of inflammatory cytokines and thereby plays an important role in 
initiation of periodontal disease 146. 
 However, according to the bivariate logistic regression analysis in the present 
study, there was no significant difference in cytokine concentration in GCF between 
subjects with or without pathological periodontal pockets.  
The enhanced level of the pro-inflammatory cytokines IL-1β and IL-8 
demonstrated in GCF from the obese adolescents are in line with the findings in adults 
demonstrating an association between obesity and IL-1β as well as PGE2 levels in 
GCF147. Previously, our research group reported that the level of TNF-α in GCF was 
correlated with BMI of the most severe obese subjects 107. The current study, however, 
did not demonstrate higher GCF level of TNF-α in obese subjects compared to 
controls, which probably is due to the fact that the subjects were younger and BMI in 
the present obese subjects was lower, indicating a shorter duration and/or less severe 
obesity.  
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MICROBIOTA IN THE ORAL SUBGINGIVAL BIOFILM (STUDY II) 
The sum of bacterial cells was significantly higher among subjects in the obesity 
group (P< 0.001) as compared to the controls. On average, approximately three-fold 
higher amounts of bacterial cells were found in the samples from the obesity subjects 
compared with normal weight controls.  Out of six bacterial phyla determined, five 
were found at higher counts in the obese subjects and counts of all families under 
these phyla were significantly higher (P< 0.001) in the obese subjects (figure 4). Of the 
Proteobacteria phylum, the bacteria Campylobacter rectus and Neisseria mucosa were 
present in six-fold higher amounts among obese subjects compared with the normal 
weight group.  There was no difference between the groups concerning bacteria in the 
Spirochaetes phylum.  
From the total of 40 different bacterial species determined in the bacterial samples, 
32 species were present in significantly higher amounts (P< 0.01 level) in the obese 
subjects compared to the normal weight controls. 
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Figure 4. The sum of assessed bacterial cells (x 105) from obese and normal weight 
subjects. Presented by family. 
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After adjusting for VPI%, BOP%, chronic disease, tooth brushing habits or salivary 
flow rate (ml/min), there was a significant association between bacterial cell count 
and the dependent variable obesity (OR= 1.05, P= 0.006). Although the OR of “sum of 
bacterial cells” seems to be low (1.05), one has to consider that an increase from 1x105 
to 1x106 bacteria enhances the risk for obesity by 50%, indicating potential clinical 
relevance. 
This was the first study demonstrating an association between obesity and an 
alteration of the subgingival microbiota in adolescents, although increased counts of 
T. forsythia colonizing the periodontal pockets have previously been demonstrated in 
obese adults 108. We demonstrated that traditional periodontal pathogens such as 
Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans and Parvimonas micra 
148, 149, were present at approximately three-fold increase in the dental biofilm of obese 
adolescents compared with the normal weight controls. We found approximately a 
three-fold higher level of the phylum Firmicutes and approximately a four-fold higher 
level of the phylum Bacteroidetes in the subgingival biofilm of obese adolescents. 
There was no significant difference of the relative proportion of Firmicutes and 
Bacteroidetes in the dental biofilm between obesity and controls. In the gut, however, 
obese subjects had relatively more Firmicutes but less Bacteroidetes compared with 
lean controls 30. Results from animal studies support the hypothesis that  gut bacteria 
influences development of obesity, especially the Firmicutes phylum that in mice 
promotes absorption of monosaccharides in the gut that results in enhanced 
lipogenesis 150. Approximately one gram of oral bacteria corresponding to 
approximately 1011 cells are swallowed daily with the 500 to 1500 ml of saliva 
produced 148. The high amount of oral microbiota ingested may affect energy 
harvesting in the gut and thereby be involved in the development of obesity.  
However, it is unknown in what amounts and proportions oral bacteria ingested will 
survive the defense barriers of the gastrointestinal tract.  
Oral microbiota plays a major role in the nitrate to nitrite conversion which in its 
turn is important in regulating blood pressure 151, 152. Interestingly, it was reported that 
the number of nitrate reducing bacteria was greatly reduced in the oral cavity of rats 
treated with daily application of antiseptic mouthwash  indicating a possible role of 
oral microbiota in regulating blood pressure and thereby in general health 153. In 
addition, a link between an increased loading of periodontal pathogens in subgingival 
plaque and hypertension has been demonstrated 154. 
Whether the alteration of the oral microbiota promotes the development of obesity 
in adolescents or is a consequence of the obese condition or, alternatively, is induced 
by life-style associated conditions is an essential issue for further research.  
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PATHOLOGICAL PERIODONTAL POCKETS, DIASTOLIC BLOOD 
PRESSURE AND INFLAMMATORY MARKERS IN BLOOD SERUM 
(STUDY III) 
Adolescents with PD≥ 4mm (n=14) had significantly higher means of diastolic 
blood pressure (P= 0.008) than adolescents without PD≥ 4mm (n= 61). There was no 
significant difference between adolescents with and without pathological periodontal 
pockets (PD≥ 4mm) in regards to age, gender, BMI-sds, tooth brushing habits, 
sociodemographic factors, medical history or VPI> 25%.  Generally, the average 
diastolic blood pressure for 14.5 year old normal weight adolescents is 63 mmHg, and 
the cut off point for prehypertension has been suggested to be at 78 mmHg155. Based 
on this consideration, approximately 12% of the obese subjects in our study exhibited 
prehypertension on the day the measurements were taken. The average diastolic 
blood pressure for obese adolescents is reported to vary from 62 mmHg to 70 
mmHg156, 157 with a frequency of prehypertension of approximately 20% 158, 159. Our 
finding that there is an association between pathological periodontal pockets and 
diastolic blood pressure is compatible with the finding in a similar age group that 
overweight or obese adolescents had significantly higher blood pressure and more 
gingival inflammation than their normal weight counterparts 145.  
Obese adolescents with PD≥ 4mm had significantly higher levels of IL-6 (P< 0.001), 
Leptin (P= 0.018), MCP-1 (P= 0.049) and TSH (P= 0.004) in blood serum than 
adolescents without PD≥ 4mm (n= 61). Presence of calculus, IL-1β, IL-8, TNF-α, 
Cholesterol, Low density lipoprotein (LDL)/HDL quotient, adult Hemoglobin 1c 
(Hba1c) or CRP sensitivity did not differ significantly between the two groups.  
TSH has not previously been connected to periodontal disease but is reported to 
be enhanced in serum in obese subjects160. In this study, the subjects without PD≥ 
4mm had TSH levels corresponding to average levels in healthy individuals, whilst 
the subjects with PD≥ 4mm had relatively higher levels. Interestingly, it has been 
reported that increases in TSH levels are associated with increases in both systolic and 
diastolic blood pressure as well as other cardiovascular risk factors 161-163. The higher 
levels of IL-6, TSH and Leptin in serum in obese adolescents with PD≥ 4mm further 
supports the notion that periodontal disease is part of a systemic inflammation that 
might, in the long run, lead to atherosclerosis and CVD 164, 165. 
In addition, a recent study demonstrated that adolescents diagnosed with three or 
more metabolic syndrome parameters are more likely to display gingival 
inflammation than healthy individuals 166. The systemic inflammatory response that 
accompanies periodontal disease has been proposed as a possible link between 
periodontal disease, atherosclerosis and its cardiovascular ill-effects 167, 168.  
There is a well-established association between oral and cardiovascular co-
morbidity in adults 169 and diastolic blood pressure at 18 years of age has been 
suggested as a stronger predictor for cardiovascular mortality than systolic blood 
pressure 170. However, more longitudinal studies are needed before pathological 
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periodontal pockets in children with obesity can be suggested as an early marker for 
future cardiovascular events. 
SALIVARY FLOW AND INFLAMMATORY BIOMARKERS (STUDY IV) 
Obese subjects demonstrated significantly lower flow rate of stimulated whole 
saliva (p< 0.001). The mean value of stimulated whole saliva flow rate was 2.0 ml/min 
of the normal weight controls compared with 1.3 ml/min of obese subjects.  
A bivariate logistic regression analysis was performed with stimulated whole 
saliva (<1.5ml/min) as dependent variable. Obesity, in terms of BMI-sds as 
continuous variable, was significantly associated with salivary flow rate (<1.5ml/min) 
(p< 0.001). 
The significant association between salivary flow rate <1.5ml/min and BMI-sds 
remained even when adjusting for age, gender, chronic disease, drugs affecting 
salivary flow, PD< 4mm, IL-1β, IL-8 and Insulin.  
Salivary flow rate <1.5ml/min was significantly associated with the biomarkers 
IL-1β (p= 0.026), IL-8 (p= 0.013) and Insulin (p= 0.043). Using multivariate logistic 
regression models we further tested the association between salivary flow rate 
(<1.5ml/min) and the significant independent variables IL-1β and IL-8.  In the 
multivariate logistic regression model, the levels of the biomarkers IL-1β and IL-8 
were significantly associated with salivary flow rate <1.5ml/min even after adjusting 
for age, gender, chronic disease, drugs affecting salivary flow, PD> 4mm and protein 
content in saliva. In agreement with previous findings we here demonstrate that obese 
adolescent’s exhibit reduced salivary flow rate compared to normal weight 
adolescents 80, 171 which also has been reported among young adults 80, 81, but not in 
children under 12 years 83, 84. There are several reasons why younger children do not 
exhibit an association between reduced salivary flow and obesity. There is the 
possibility that sample taking is more difficult in a very young population. In 
addition, one has to consider that the duration and exposition time to obesity is 
shorter, which might have an influence on the results. 
 The finding that obese subjects present reduced salivary flow rate is well 
compatible with a recent study reporting that in a group of morbidly obese patients, 
the stimulated salivary flow significantly increased after weight loss following gastric 
bypass surgery 172. 
Obese adolescents also demonstrated higher levels of salivary Insulin (p< 0.001), 
Leptin (p= 0.005), CRP (p= 0.002) and INF-γ (p= 0.011). The quota between T-helper 
cells (Th)-1 and Th-2 related cytokines (INF-γ/ IL-4) was higher in the obese group 
(0.73) compared to normal weight adolescents (0.44) (p=0.020).  
Although the salivary levels of Leptin, Insulin and CRP were significantly higher 
in obese adolescents than in their normal weight counterparts, these inflammatory 
biomarkers were, according to the results, not associated with reduced salivary flow 
rate.  
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The mean CRP level in saliva was approximately five times higher in obese 
adolescents than in their normal weight counterparts. Salivary CRP concentration has 
been found to correlate well with serum concentration 173. Human studies have 
associated high levels of CRP with metabolic syndrome and type 2 diabetes 83, 174.  
Leptin level in saliva was 11 times higher in the obese subjects compared to normal 
weight subjects. Leptin is produced by adipocytes and binds to leptin receptor in 
hypothalamus to suppress food intake and increase energy consumption. Reduced 
sensitivity to this molecule might trigger the onset of obesity 95.  More recently, Leptin 
has also been demonstrated to influence the immune systems balance 175, and it is 
interesting to note that leptin concentrations in saliva are significantly lower in 
subjects with chronic periodontal disease,  whilst serum levels are significantly higher 
and relate closely to current disease activity 176.  
Concentration of Insulin in saliva is known to correlate well with serum levels of 
Insulin 177 and the results in the present study are well in line with previous findings 
describing  increased Insulin levels in saliva from obese individuals 83.  
Presumably, the higher levels of CRP, Leptin and Insulin in saliva are reflecting a 
systemic metabolic change in obesity but does not seem to be directly associated with 
reduced saliva flow rate. However, as the increased levels of CRP, Leptin and insulin 
does reflect a systemic inflammation, they might indirectly affect salivary flow. 
Systemic inflammation and autoimmune disease, such as Sjögren’s syndrome and 
rheumatoid arthritis, often involve salivary glands with reduced salivary flow as a 
consequence 178.  
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LIMITATIONS 
All studies in this thesis are of a cross-sectional design, giving us results at one 
moment in time. Longitudinal studies are needed before any permanent conclusions 
can be drawn. In addition, experimental studies would be necessary to evaluate cause 
and effect mechanisms behind cross-sectional and longitudinal statistical associations. 
We did not register the duration of obesity of the subjects in any study, which in 
addition to the severity of obesity is of importance when looking upon the association 
between obesity and oral health issues during adolescence.  
One weakness of these studies is that the amount of preventive care given to our 
patients is not possible to analyze. One cannot rule out that prevention care differs 
between the groups, which may affect the strength of the link between obesity and 
oral co-morbities.  
Another weakness in these studies is the possible influence of socioeconomic 
factors. Although we took into consideration parents’ education and country of birth 
there are other socioeconomic variables that could affect the subjects’ oral and general 
health.  
A weakness to take into consideration as well is that in Study III,  one-time blood 
pressure measurement in a resting position was used, which is an acceptable 
screening method 179. However, to diagnose a child or adolescent with hypertension, 
a 24 hour evaluation is recommended. 155, 180.  
In Study III, as well, no normal weight participants were included and therefore, 
the association between periodontal disease and raised diastolic blood pressure might 
be specific for the obese condition.  Future research is needed and should include a 
normal weight control group in order to investigate if there is a general association 
between blood pressure and periodontal disease.  
We used the median value of flow rate of stimulated whole saliva (1.5ml/min) as 
the cut off value in the multiple logistic regression analysis in Study IV since there is 
lack of valid reference in adolescents regarding reduced flow rate of whole saliva.  
Saliva samples were mostly taken between one and three o’clock in the afternoon 
but not strictly at the same time, which may to some extent influence the secretion rate 
due to circadian rhythm of salivary flow rate 81. Clinical studies using standardized 
saliva collection procedure that includes point of time are needed to confirm the 
current and previous observation of reduced salivary flow rate in subjects with 
obesity.  
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MAIN FINDINGS 
 There is an association between obesity and pathological periodontal 
risk indicators in adolescents.  
 
 Oral bacterial cells counts in the subgingival biofilm are associated 
with obesity in adolescence. 
 
 Periodontal disease in terms of pathological periodontal pockets is 
associated with diastolic blood pressure in obese adolescents. 
 
 Obesity in adolescents is associated with reduced flow rate of 
stimulated whole saliva. 
 
 Low salivary flow rate in adolescents is associated with enhanced 
levels of inflammatory markers IL-1β and IL-8 in saliva. 
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CLINICAL IMPLICATIONS 
Obesity in adolescents is associated with inadequate oral hygiene habits, declined 
oral health in terms of VPI% and BOP% as well as PD≥ 4mm, indicating more 
periodontal inflammation than in their normal weight counterparts.  
The Public Dental Service may want to consider the knowledge that periodontal 
disease is more frequent and stimulated whole saliva flow rate is reduced in 
adolescents with obesity in developing a prevention plan for this group of patients. 
In conclusion, these results call for collaboration between pediatric dentists and 
pediatric medical physicians in developing a prevention program for obesity and its 
associated disorders in children and adolescents.  
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